Thanks for that. I suppose that even without promoting individual products, the fact that some will be on show along with details of their growing customer base would give weight to Fruitflow's potential. It could hardly be classed as a novel ingredient these days and that would reduce the perception of risk to any prospective customers. Although not substantiated, promotion of the potential for blood pressure reduction and memory loss could increase its attractiveness. I suspect DSM are more aware than us underlings of trial progress, and if positive, could possibly use the data. Would be interesting to hear from anyone attending what the response is to questions about the ongoing trials. Do you know anyone this time Gixer?
"How likely do you think it is that DSM will promote the PXS product"
Probably not very likely but who knows but they regularly have finished products on their stand at exhibitions. There maybe 60+ ff products on the market but there are only 3 ff - omega products among the 60 and it would be good to think that they would push the combo that they developed with Aenova and help us out after the long delay.
There is also a finished products section at the show and although DSM is not listed Aenova is. http://www.vitafoods.eu.com/welcome/finished-products
Some info on DSM - Aenova - Coronarflow (Fruitflow + Omega) http://www.nutraceuticalsnow.com/articles/2013/04/06/coronar-flow/
How likely do you think it is that DSM will promote the PXS product, beyond using it to illustrate how Fruitflow can be marketed to the consumer. Having never been to one of these events, I'm not aware of how much promotion they do for individual products, particularly now there are 60+ products in the marketplace. Regarding Aenova, this is the first time I've been made aware of the company, so unsure of their significance (forgive my ignorance)
Excellent coverage of the benefits of Fruitflow;- sirco drink mainly talked about; but this was June 2015 and still PXS share price is so low. However, we are all supporting a natural way to keep healthy and I go to the gym regularly and take my Fruitflow product. https://www.youtube.com/watch?v=MlRh98smN2Y
Omega 3 first became interesting topic in the 1980's but took until 2004 before it was accepted in the USA as a possible beneficiary in matters of cardiovascular health. It is still considered as only having limited heart health benefits. Bring on the Fruitflow, I say. But shows how long time frames can be when introducing new health products and convincing those that need convincing, all be it that the medical profession is still controlled by the large pharma's.
Prompted by ADM04's graph and the speed with which further finds by Gixer updated it, I thought back to Asshur's comparison between Fruitflow and Omega3 and how the latter took time to be established before take off. I have looked for a graph of the adoption curve for Omega3 either showing the number of companies who took it up or the growth of consumption. Others may find something better but all I could find was a graph showing the import of Omega3 into the USA, the major market. It shows a low relatively unchanging level of import between 1989 and about 2005/06, then take off. Where are we on this sort of curve? Has our past Sirco phase taken us through the early adopters phase, equivalent to Omega3 down to 2005/6. Does ADM04's graph show that we have started a climb equivalent to what happened to Omega3's consumption in the States at least after 2005/06? One wonders whether, hidden behind the raw data showing the increasing number of new products in ADM04's graph, there is also a slow increase in the size of company involved. The last product certainly seems to involve a large company. If the number of new products is being underpinned by larger and larger companies, ones use to dealing at a larger and larger scale, that would help turbocharge sales. We can only hope.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.